Viewing Study NCT00517920



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00517920
Status: COMPLETED
Last Update Posted: 2013-01-04
First Post: 2007-08-16

Brief Title: Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma HCC
Sponsor: AbbVie prior sponsor Abbott
Organization: AbbVie

Study Overview

Official Title: An Open-Label Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced Hepatocellular Carcinoma HCC
Status: COMPLETED
Status Verified Date: 2013-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma HCC
Detailed Description: An Open-label Phase 2 study of efficacy and tolerability of ABT-869 in advanced hepatocellular carcinoma HCC

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None